{"mainPropery":{"diseaseId":7830,"diseaseName":"Tuberous sclerosis complex","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7830/tuberous-sclerosis-complex","synonyms":["Tuberous sclerosis","Bourneville syndrome"],"synonyms-with-source":[{"name":"Tuberous sclerosis","source":"Orphanet"},{"name":"Bourneville syndrome","source":"Orphanet"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"805"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases"},{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":706,"resourceName":"Tuberous Sclerosis Alliance","abbreviation":"TS Alliance","address1":"801 Roeder RD, Suite 750","address2":"","address3":"","address4":"","address5":"","city":"Silver Spring","state":"MD","zip":"20910-4487","country":"United States","phone":"+1-301-562-9890 ","tty":"","tollFree":"1-800-225-6872","fax":"+1-301-562-9870","email":"info@tsalliance.org","url":"https://www.tsalliance.org/","freeText":"For immediate support or information, please email Dena Hook at dhook@tsalliance.org."}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=Tuberous+sclerosis' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Tuberous sclerosis complex. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Tuberous+sclerosis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Tuberous sclerosis complex. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://medlineplus.gov/genetics/condition/tuberous-sclerosis-complex/' target='_blank'>MedlinePlus Genetics</a> contains information on Tuberous sclerosis complex. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":400,"resourceId":1211,"resourceName":"Tuberous Sclerosis Alliance LAM test","descriptionText":"The <a href='http://www.tsalliance.org/pages.aspx?content=647 ' target='_blank'>Tuberous Sclerosis Alliance</a> provides information about a new diagnostic test for lymphangioleiomyomatosis (LAM). This testÂ measures vascular endothelial growth factor D (VEGF-D), which is known to be elevated in the blood of people with LAM, including those with tuberous sclerosis. ","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1854465' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/tuberous-sclerosis/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/tuberoussclerosis.html' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Tuberous-Sclerosis-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1112322-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=805' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1220/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_TuberousSclerosis.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1744,"resourceId":2898,"resourceName":"RDCRN - Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations","descriptionText":"The <a target=\"_blank\" href=\"https://www.rarediseasesnetwork.org/DSC/index.htm\">Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations Consortium</a> is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research on Tuberous Sclerosis Complex (TSC1 and TSC2 genes), PTEN ASD/ID syndrome and Phelan-McDermid syndrome (PMS; SHANK3 gene). The Consortium has a contact registry for patients who wish to be contacted about clinical research opportunities and updates on the progress of the research projects.\r\n<br />\r\n<br />\r\nFor more information on the registry see: <a target=\"_blank\" href=\"https://www.rarediseasesnetwork.org/registry/index.htm\">https://www.rarediseasesnetwork.org/registry/index.htm</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1846,"resourceId":3031,"resourceName":"Genetics Education Materials for School Success","descriptionText":"The <a href='http://www.gemssforschools.org/conditions/tuberous_sclerosis/default' target='_blank'>Genetics Education Materials for School Success (GEMSS)</a> aims to assure that all children with genetic health conditions succeed in school-life. Their Web site offers general and condition-specific education resources to help teachers and parents better understand the needs of students who have genetic conditions.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Education Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:13515' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2160,"resourceId":3368,"resourceName":"Patient Access Network Foundation","descriptionText":"<a href='https://panfoundation.org/index.php/en/patients/assistance-programs/tuberous-sclerosis-complex' target='_blank'>Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":3760,"questionText":"What is tuberous sclerosis complex?","answerText":"<strong>Tuberous sclerosis complex (TSC) </strong>is characterized by&nbsp;the growth of benign tumors throughout the body, including in the heart, brain, and kidneys. Certain symptoms develop before to birth, such as heart tumors (rhabdomyoma). Other symptoms become more obvious in childhood, such as developmental delay and skin changes. Lung and kidney tumors are more likely to develop in adulthood. TSC is caused by the&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/TSC1\" target=\"_blank\">TSC1</a></em> or <em><a href=\"https://ghr.nlm.nih.gov/gene/TSC2\" target=\"_blank\">TSC2</a></em> gene not working correctly. It is inherited in an autosomal dominant pattern. This condition is diagnosed based on a clinical exam, medical tests such as imaging studies, and genetic testing. Treatment is based on managing the symptoms, and includes medications and surgery.[15579][15580][15581][15582]","dateModified":"2020-05-20T00:00:00"},"basicQuestions":[{"questionId":13462,"questionText":"What are the signs and symptoms of tuberous sclerosis complex?","answerText":"The following list includes the most common signs and symptoms in people with tuberous sclerosis complex (TSC). These features may be different from person to person. Some people may have more symptoms than others and symptoms can range from mild to severe. This list does not include every symptom or feature that has been described in this condition.[15579][11544]<br />\r\n<br />\r\nSigns and symptoms include:<br />\r\n<br />\r\nSkin findings:\r\n<ul>\r\n    <li>Small bumps made up of blood vessels (angiofibromas)</li>\r\n    <li>Patches of thickened, rough skin (shagreen patches)</li>\r\n    <li>Growths under the fingernails and toenails (ungual fibromas)</li>\r\n    <li>Light colored skin patches (hypomelanonic macules)</li>\r\n</ul>\r\nBrain findings:\r\n<ul>\r\n    <li>Benign brain tumor (astrocytoma)</li>\r\n    <li>Abnormal organization of the brain (cortical dysplasia)</li>\r\n    <li>Nodules in the brain (subependymal nodules)</li>\r\n    <li>Seizures</li>\r\n</ul>\r\nOther systems:\r\n<ul>\r\n    <li>Benign growth in the retina (retinal hamartoma)</li>\r\n    <li>Heart muscle tumor (cardiac rhabdomyoma)</li>\r\n    <li>Formation of unusual clumps of cells in the lungs (pulmonary lymphangiomyomatosis)</li>\r\n    <li>Kidney growths (renal angiomyolipoma)</li>\r\n    <li>Developmental delay</li>\r\n    <li>Intellectual disability</li>\r\n    <li>Behavioral issues</li>\r\n</ul>\r\nSymptoms of tuberous sclerosis complex begin before birth and might be noted on ultrasound, such as tumors in the brain and heart (subependymal nodules and cardiac rhabdomyomas). Seizures, intellectual disability, and developmental delay usually appear in childhood. Other symptoms that might develop in childhood include skin changes and kidney symptoms caused by tumors. Brain tumors usually grow during childhood and in teen years, which may lead to other concerns, such as <a href=\"https://medlineplus.gov/hydrocephalus.html\" target=\"_blank\">hydrocephalus</a>. In adulthood, kidney and pulmonary symptoms become more common.[15581][15583]","dateModified":"2020-05-20T19:11:00","resourceClassificationName":"Symptoms","references":[{"referenceId":11544,"authors":"Northrup H, Koenig MK, Pearson DA, Au K-S","articleTitle":"Tuberous Sclerosis Complex","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Apr 16, 2020","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1220/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15579,"authors":"Northrup H, Krueger DA","articleTitle":"International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","bookWebsiteJournalTitle":"Pediatr Neurol","date":"2013","volume":"49(4)","pages":"243-254","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080684/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15581,"authors":"Peron A, Canevini MP, Ghelma F, Di Marco F, Vignoli A","articleTitle":"Healthcare transition from childhood to adulthood in Tuberous Sclerosis Complex","bookWebsiteJournalTitle":"Am J Med Genet C Semin Med Genet","date":"2018","volume":"178(3)","pages":"355-364","url":"https://pubmed.ncbi.nlm.nih.gov/30253036","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15583,"authors":"De Waele L, Lagae L, Mekahli D","articleTitle":"Tuberous sclerosis complex: the past and the future","bookWebsiteJournalTitle":"Pediatr Nephrol","date":"Oct 2015","volume":"30(10)","pages":"1771-80","url":"https://www.ncbi.nlm.nih.gov/pubmed/25533384","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13466,"questionText":"How is tuberous sclerosis complex inherited?","answerText":"Tuberous sclerosis complex (TSC) is inherited in an autosomal dominant pattern.&nbsp;All individuals inherit two copies of each gene.[11544] Autosomal means the gene is found on one of the numbered chromosomes found in both sexes. Dominant means that only one altered copy of a gene is necessary to have the condition. The alteration can be inherited from either parent. Sometimes an autosomal dominant condition occurs because of a new genetic alteration (de novo) and there is no history of this condition in the family.<br />\r\n&nbsp;&nbsp;<br />\r\nEach child of an individual with an autosomal dominant condition has a 50% or 1 in 2 chance of inheriting the alteration and the condition. Typically, children who inherit a dominant alteration will have the condition, but they may be more or less severely affected than their parent. Sometimes a person may have a gene alteration for an autosomal dominant condition and show no signs or symptoms of the condition.&nbsp;&nbsp;<br />","dateModified":"2020-05-21T12:11:00","resourceClassificationName":"Inheritance","references":[{"referenceId":11544,"authors":"Northrup H, Koenig MK, Pearson DA, Au K-S","articleTitle":"Tuberous Sclerosis Complex","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Apr 16, 2020","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1220/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13463,"questionText":"How is tuberous sclerosis complex diagnosed?","answerText":"A diagnosis of tuberous sclerosis complex is made based on a clinical exam and identification of specific symptoms. Diagnostic criteria have been published for this condition. Genetic testing&nbsp;can confirm the diagnosis.[15579]<br />\r\n<br />\r\n<br />","dateModified":"2020-05-21T11:38:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":15579,"authors":"Northrup H, Krueger DA","articleTitle":"International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","bookWebsiteJournalTitle":"Pediatr Neurol","date":"2013","volume":"49(4)","pages":"243-254","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080684/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13464,"questionText":"How might tuberous sclerosis complex be treated?","answerText":"The treatment for tuberous sclerosis complex is based on managing the symptoms in each person. A type of medication can be helpful in slowing or stopping the growth of some of the associated tumors; including renal angiomyolipomas, subependymal giant cell astrocytomas, lymphangioleiomyomatosis, and facial angiofibromas. In some cases, surgery may be needed.[15580][15583]<br />\r\n<br />\r\nSpecialists who may be involved in the care of someone with tuberous sclerosis complex include:<br />\r\n<ul>\r\n    <li>Cardiologist</li>\r\n    <li>Dermatologist</li>\r\n    <li>Nephrologist</li>\r\n    <li>Neurologist</li>\r\n    <li>Ophthalmologist</li>\r\n    <li>Pulmonologist</li>\r\n    <li>Urologist</li>\r\n    <li>Medical geneticist</li>\r\n    <li>Dentist</li>\r\n</ul>","dateModified":"2020-05-21T11:45:00","resourceClassificationName":"Treatment","references":[{"referenceId":15580,"authors":"Krueger DA, Northrup H","articleTitle":"International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","bookWebsiteJournalTitle":"Pediatr Neurol","date":"2013","volume":"49(4)","pages":"255-265","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058297/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15583,"authors":"De Waele L, Lagae L, Mekahli D","articleTitle":"Tuberous sclerosis complex: the past and the future","bookWebsiteJournalTitle":"Pediatr Nephrol","date":"Oct 2015","volume":"30(10)","pages":"1771-80","url":"https://www.ncbi.nlm.nih.gov/pubmed/25533384","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13467,"questionText":"How many people have tuberous sclerosis complex?","answerText":"The exact number of people with tuberous sclerosis complex is unknown.&nbsp; It has been estimated that about 40,000 people in the United States have tuberous sclerosis complex.[15584]","dateModified":"2020-05-21T12:16:00","resourceClassificationName":"Statistics","references":[{"referenceId":15584,"authors":"Hyman MH, Whittemore VH","articleTitle":"National Institutes of Health consensus conference: tuberous sclerosis complex","bookWebsiteJournalTitle":"Arch Neurol","date":"May 2000","volume":"57(5)","pages":"662-5","url":"https://www.ncbi.nlm.nih.gov/pubmed/10815131","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13465,"questionText":"What is the cause of tuberous sclerosis complex?","answerText":"Tuberous sclerosis complex (TSC) is caused by the&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/TSC1\" target=\"_blank\">TSC1</a></em> or <em><a href=\"https://ghr.nlm.nih.gov/gene/TSC2\" target=\"_blank\">TSC2</a></em> gene not working correctly.[11544]&nbsp; DNA changes known as <a href=\"https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genetic-variant\" target=\"_blank\">pathogenic variants</a> are responsible for making genes work incorrectly or not at all.&nbsp;","dateModified":"2020-05-21T12:06:00","resourceClassificationName":"Cause","references":[{"referenceId":11544,"authors":"Northrup H, Koenig MK, Pearson DA, Au K-S","articleTitle":"Tuberous Sclerosis Complex","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Apr 16, 2020","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1220/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":11544,"authors":"Northrup H, Koenig MK, Pearson DA, Au K-S","articleTitle":"Tuberous Sclerosis Complex","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Apr 16, 2020","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1220/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15579,"authors":"Northrup H, Krueger DA","articleTitle":"International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","bookWebsiteJournalTitle":"Pediatr Neurol","date":"2013","volume":"49(4)","pages":"243-254","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080684/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15580,"authors":"Krueger DA, Northrup H","articleTitle":"International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","bookWebsiteJournalTitle":"Pediatr Neurol","date":"2013","volume":"49(4)","pages":"255-265","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058297/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15581,"authors":"Peron A, Canevini MP, Ghelma F, Di Marco F, Vignoli A","articleTitle":"Healthcare transition from childhood to adulthood in Tuberous Sclerosis Complex","bookWebsiteJournalTitle":"Am J Med Genet C Semin Med Genet","date":"2018","volume":"178(3)","pages":"355-364","url":"https://pubmed.ncbi.nlm.nih.gov/30253036","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15582,"authors":"Caban C, Khan N, Hasbani DM, Crino PB","articleTitle":"Genetics of tuberous sclerosis complex: implications for clinical practice.","bookWebsiteJournalTitle":"Appl Clin Genet","date":"2016","volume":"10","pages":"1-8","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189696/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15583,"authors":"De Waele L, Lagae L, Mekahli D","articleTitle":"Tuberous sclerosis complex: the past and the future","bookWebsiteJournalTitle":"Pediatr Nephrol","date":"Oct 2015","volume":"30(10)","pages":"1771-80","url":"https://www.ncbi.nlm.nih.gov/pubmed/25533384","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15584,"authors":"Hyman MH, Whittemore VH","articleTitle":"National Institutes of Health consensus conference: tuberous sclerosis complex","bookWebsiteJournalTitle":"Arch Neurol","date":"May 2000","volume":"57(5)","pages":"662-5","url":"https://www.ncbi.nlm.nih.gov/pubmed/10815131","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":12563,"relatedDiseaseName":"Lymphedema","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[{"caseId":28239,"abbreviatedInquiry":"Can tuberous sclerosis affect blinking and eye closure? If not, what could cause this?","caseQuestions":[{"questionId":3761,"questionText":"Can tuberous sclerosis affect blinking and eye closure? If not, what could cause this?","answerText":"Lagophthalmos is&nbsp;the medical term for \"incomplete closure of the eyelid.\"&nbsp;Lagophthalmos can cause drying, infection, corneal ulceration, corneal perforation, and loss of vision.[2650] <br><br>Lagophthalmos is often caused by&nbsp;facial palsy.[2652]&nbsp;Facial palsy may&nbsp;be due to&nbsp;a variety of conditions and factors, including&nbsp;Bell's palsy, trauma, infection, or tumors.&nbsp;&nbsp;Lagophthalmos can occur as a result of bulging eyes (e.g.,&nbsp;as in&nbsp;Graves disease), or&nbsp;in individuals whose face has suffered scarring. Other causes, include&nbsp;ocular cicatrical pemphigoid, erythema multiforme, leprosy,&nbsp;chronic alcoholism, dementia, parkinsonism, general anesthesia, and coma. Temporary lagophthalmos can occur in infants or in people during sleep.[2650][2651][2652] \r\n<p>Treatment may include artificial tears, eye ointment, moisture chambers, or surgery.[2650] <br><br>It is possible that a tuberous sclerosis related tumor or complication could&nbsp;cause&nbsp;lagophthalmos.&nbsp;If you or a loved one has tuberous sclerosis and is experiencing lagophthalmos we strongly recommend that you speak with a geneticist or other healthcare professional who can help you determine the underlying cause of the condition. </p>\r\n<div id=ctrlQuestionManager_RadEditor2>Genetic professionals are a source of information for individuals and families regarding genetic diagnosis, natural history, treatment, mode of inheritance, and genetic risks to other family members. To find a genetics clinic, we recommend that you contact your primary doctor for a referral. <a title=http://ghr.nlm.nih.gov/handbook/consult?show=all href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=_blank>Click here</a> to learn more about genetic consultations.</span> \r\n<p>The following online resources can also help you find a genetics professional in your community: </p>\r\n<p>&nbsp; * GeneTests - A searchable directory of US and international genetics and prenatal diagnosis clinics. Go to the following link and click on 'Clinic Directory' to find a genetic service close to you.<br><a href=\"http://www.geneclinics.org/\" target=_blank>http://www.geneclinics.org/</a></p>\r\n<p>&nbsp; * ResourceLink - A database of genetics counseling services, searchable by location, name, institution, type of practice, or specialty. Hosted by the National Society of Genetic Counselors.<br><a href=\"http://www.nsgc.org/resourcelink.asp\" target=_blank>http://www.nsgc.org/resourcelink.asp</a></p>\r\n<p>&nbsp; * Genetic Centers, Clinics, and Departments - A comprehensive resource list for genetic counseling, including links to genetic centers and clinics, associations, and university genetics departments. Hosted by the University of Kansas Medical Center. <br><a href=\"http://www.kumc.edu/gec/prof/genecntr.html\" target=_blank>http://www.kumc.edu/gec/prof/genecntr.html</a></p></div>\r\n<p>&nbsp; * The American Society of Human Genetics (ASHG) is a professional organization of research and clinical geneticists. The ASHG maintains a database of these geneticists, some of which live outside of the United States. If you are interested in obtaining a list of the geneticists in your area, some of which may only be researchers and may not offer medical care, please visit the following hyperlink, to search.<br><a href=\"http://genetics.faseb.org/cgi-bin/ASHG-Search\" target=_blank><u>http://genetics.faseb.org/cgi-bin/ASHG-Search</u></a></p>","dateModified":"2010-10-29T16:51:00","references":[{"referenceId":2650,"authors":"Olitsky SE, Hug D, Smith LP. ","articleTitle":"","bookWebsiteJournalTitle":"Nelson Textbook of Pediatrics, 18th ed","date":"2007","authors2":"Kliegman","placeOfPublication":"Philadelphia, PA","publisher":"Saunders"},{"referenceId":2651,"authors":"McLeod SD","articleTitle":"Bacterial Keratitis","bookWebsiteJournalTitle":"Ophthalmology, 3rd ed","date":"2008","authors2":"Yanoff & Duker","placeOfPublication":"Philadelphia, PA","publisher":"Mosby"},{"referenceId":2652,"authors":"Pereira MV","articleTitle":"Lagophthalmos","bookWebsiteJournalTitle":"Semin Ophthalmol","date":"01 May 2010"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14215,"phenoTypeName":"Cortical dysplasia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15144,"phenoTypeName":"Cortical tubers","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4197,"phenoTypeName":"Generalized abnormality of skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15146,"phenoTypeName":"Hypomelanotic macule","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15143,"phenoTypeName":"Subependymal nodules","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":2455,"phenoTypeName":"Abnormal social behavior","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6013,"phenoTypeName":"Aggressive behavior","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2754,"phenoTypeName":"Angiofibromas","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6012,"phenoTypeName":"Autism","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15156,"phenoTypeName":"Cardiac rhabdomyoma","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5551,"phenoTypeName":"Chorioretinal hypopigmentation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":58,"phenoTypeName":"Confetti-like hypopigmented macules","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6011,"phenoTypeName":"Depressivity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13680,"phenoTypeName":"Focal-onset seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11798,"phenoTypeName":"Impulsivity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15420,"phenoTypeName":"Infantile spasms","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9043,"phenoTypeName":"Neurodevelopmental delay","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8791,"phenoTypeName":"Pulmonary lymphangiomyomatosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4682,"phenoTypeName":"Repetitive compulsive behavior","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11801,"phenoTypeName":"Self-injurious behavior","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15148,"phenoTypeName":"Shagreen patch","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":958,"phenoTypeName":"Skin plaque","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11439,"phenoTypeName":"Sleep disturbance","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9417,"phenoTypeName":"Specific learning disability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13751,"phenoTypeName":"Status epilepticus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14132,"phenoTypeName":"Anxiety","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4486,"phenoTypeName":"Attention deficit hyperactivity disorder","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":965,"phenoTypeName":"Epidermoid cyst","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13737,"phenoTypeName":"Hemoptysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11308,"phenoTypeName":"Hepatic cysts","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6027,"phenoTypeName":"Hypertension","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8137,"phenoTypeName":"Noncommunicating hydrocephalus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5225,"phenoTypeName":"Poor speech","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12116,"phenoTypeName":"Renal angiomyolipoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13728,"phenoTypeName":"Respiratory distress","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13217,"phenoTypeName":"Respiratory tract infection","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15145,"phenoTypeName":"Subependymal giant-cell astrocytoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1871,"phenoTypeName":"Ungual fibroma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10911,"phenoTypeName":"Aortic aneurysm","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":1906,"phenoTypeName":"Carcinoid tumor","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":14101,"phenoTypeName":"Internal hemorrhage","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":2307,"phenoTypeName":"Pancreatic endocrine tumor","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4306,"phenoTypeName":"Parathyroid adenoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":1382,"phenoTypeName":"Parathyroid hyperplasia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13292,"phenoTypeName":"Pheochromocytoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4302,"phenoTypeName":"Pituitary adenoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10044,"phenoTypeName":"Polycystic kidney dysplasia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":15049,"phenoTypeName":"Renal cell carcinoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4292,"phenoTypeName":"Respiratory failure","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8774,"phenoTypeName":"Retinal astrocytic hamartoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":7355,"phenoTypeName":"Stage 5 chronic kidney disease","frequencyText":"Very rare","percentRanges":"1%-4%"}],"medicalProducts":[{"productId":530,"genericName":"Everolimus","tradeName":"Afinitor","tradeLink":"https://www.us.afinitor.com/","manufacturer":"","sponsor":"Novartis Pharmaceuticals Corporation","indication":"April 2018 approved for the adjunctive treatment of adult and pediatric patients age 2 years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures. April 2012 approved for the treatment of adults with renal angiomyolipoma and tuberous sclerosis complex (TSC) not requiring immediate surgery. October 2010 approved for the treatment of patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis who require therapeutic intervention but are not candidates for curative surgical resection.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/afinitor","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a609032.html"},{"productId":497,"genericName":"Vigabatrin","tradeName":"Sabril","tradeLink":"http://sabril.net/","manufacturer":"","sponsor":"Lundbeck","indication":"For infantile spasms (IS)\r\n1 month to 2 years of age","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/vigabatrin","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a610016.html"}],"EncodedName":"Tuberous_sclerosis_complex"}